FDA Chief Admits To Overstating Plasma Treatment Benefits
Stephen Hahn said in a series of tweets Tuesday that criticism of his remarks is "entirely justified."
The FDA's commissioner is admitting he overstated the benefits of convalescent plasma as a COVID-19 treatment.
Stephen Hahn said in a series of tweets Tuesday that criticism of his earlier remarks overstating the effectiveness of the plasma treatment is "entirely justified."
Hahn and other Trump administration officials hailed the treatment as an absolute survival benefit. But it actually hasn't been scientifically proven to be effective against the virus just yet.
Experts say more data on the treatment is needed. The FDA has authorized more hospitals to use convalescent plasma, which is taken from patients who have recovered from the coronavirus and is rich in antibodies.
Long COVID patients use experimental shot for sense of smell issues
People are traveling from around the world to a Texas center that is testing a pain medication injection as a way to treat loss of smell from COVID.By Scripps News
Why COVID vaccine outreach is still critical in 2023
Pharmacists are working to get the COVID vaccine to communities that may not have easy access to a pharmacy.By Scripps News
US proposes once-a-year COVID shots for most Americans
The FDA proposed a simplified approach for future vaccination efforts, allowing most adults and children to get a once-a-year shot to combat COVID.By Rogelio V. Solis / AP
Online system to seek asylum in US is quickly overwhelmed
The daily ritual resembles a race for concert tickets when online sales begin for a major act.By Elliot Spagat / AP
Tyre Nichols video: Here are some of the key takeaways
A fatal beating. Cries for his mom. Officers cheering each other on. Here are some of the key takeaways from the Tyre Nichols police bodycam footage.By City of Memphis via AP
Memphis disbands SCORPION Unit after Tyre Nichols' video release
The unit's disbandment comes as protests have spread throughout the city in recent days.By Gerald Herbert / AP